1.
Silymarin-choline combination versus ursodeoxycholic acid in non-alcoholic fatty liver disease: A randomized double-blind clinical trial. Asian J Med Sci [Internet]. 2024 Apr. 1 [cited 2026 Jul. 9];15(4):70-7. Available from: https://www.nepjol.info/index.php/AJMS/article/view/61970